112th Annual General Meeting of Shareholders

About the 112th Annual General Meeting

Santen Pharmaceutical Co., Ltd. held its 112th Annual General Meeting of Shareholders for the fiscal year 2023 on June 25, 2024.The Meeting started at 10:00 a.m. and ended at 10:42 a.m. The number of shareholders attended was 58.

Matters reported:	Business Report, Consolidated Financial Statements and Non-consolidated Financial Statements for the 112th Business Term (April 1, 2023 to March 31, 2024) The Audit Reports by the Accounting Auditors and the Board of Corporate Auditors on the consolidated Financial Statements for the 112th Business Term (April 1, 2023 to March 31, 2024)
Questions:	We received questions regarding the following subjects from shareholders in advance and answered each question on the Meeting. Status of recovery from the Noto Peninsula earthquake and its impact on business performance. Promotion and human resources development of the born and bred employees. Promotion of female employees to managers. Current status of the Americas business and future rechallenges. There was no question submitted by shareholders present at the Meeting.
Matters resolved:	Four proposals were all resolved. Please refer to the Resolution Notice (PDF: 134KB)PDF file.Page will open in a new window. for detailed resolutions.

Matters reported:

Business Report, Consolidated Financial Statements and Non-consolidated Financial Statements for the 112th Business Term (April 1, 2023 to March 31, 2024)
The Audit Reports by the Accounting Auditors and the Board of Corporate Auditors on the consolidated Financial Statements for the 112th Business Term (April 1, 2023 to March 31, 2024)

Questions:

We received questions regarding the following subjects from shareholders in advance and answered each question on the Meeting.

Status of recovery from the Noto Peninsula earthquake and its impact on business performance.
Promotion and human resources development of the born and bred employees.
Promotion of female employees to managers.
Current status of the Americas business and future rechallenges.

There was no question submitted by shareholders present at the Meeting.

Matters resolved:

Four proposals were all resolved.
Please refer to the Resolution Notice (PDF: 134KB)PDF file.Page will open in a new window. for detailed resolutions.

Official SNS